Pendal Group LTD Neurocrine Biosciences Inc Transaction History

Pendal Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$72.45 - $94.81 $274,150 - $358,761	-3,784 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$79.65 - $106.22 $301,395 - $401,936	3,784 New	3,784 $322,000
Q3 2021 Nov 05, 2021	SELL	$86.18 - $99.03 $296,631 - $340,861	-3,442 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$89.43 - $102.27 $307,818 - $352,013	3,442 New	3,442 $335,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.